SCHEMBL14955233

SCHEMBL14955233

N#Cc1c(O)[nH]c(=S)c(C#N)c1-c1ccco1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.59
MEN1 O00255 9/20 0.59
KMT2A Q03164 9/20 0.59
MAPT P10636 7/20 0.59
HSD17B10 Q99714 7/20 0.59
ALOX15 P16050 4/20 0.59
HPGD P15428 4/20 0.59
BLM P54132 4/20 0.59
POLB P06746 3/20 0.59
CUL4A Q13619 2/20 0.59
USP2 O75604 2/20 0.59
CASP1 P29466 2/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
MAPK1 P28482 1/20 0.59
KDM4E B2RXH2 10/20 0.56
GAA P10253 5/20 0.56
PKM P14618 3/20 0.56
LMNA P02545 2/20 0.53
TDP1 Q9NUW8 2/20 0.50
ADORA1 P30542 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6441223 0.84 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL15570369 0.74 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL16294372 0.73 CUL4A (0.66) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL21116577 0.73 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL6445065 0.72 CUL4A (0.64) ALDH1A1MEN1KMT2AMAPTHSD17B10
Ammonia Solution, Strong SCHEMBL19717396 0.72 ADORA1 (0.50) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL12822457 0.71 CUL4A (0.56) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL16296963 0.71 ALDH1A1 (0.72) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL15571075 0.69 CUL4A (1.00) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL6440926 0.69 ADORA2A (0.54) ALDH1A1MEN1KMT2AMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170121344-A1 THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS SIGA TECHNOLOGIES, INC. (US) 2017-05-04 US disclosed
WO-2014089378-A1 THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS SIGA TECHNOLOGIES, INC. (US) 2014-06-12 WO disclosed
US-20130129677-A1 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections SIGA TECHNOLOGIES, INC. (US) 2013-05-23 US disclosed
US-20130129677-A1 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections SIGA TECHNOLOGIES, INC. (US) 2013-05-23 US disclosed
US-20130129677-A1 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections SIGA TECHNOLOGIES, INC. (US) 2013-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130129677-A1 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections TTPA, TPMT, SLC19A2 ALDH1A1 1400/4885MEN1 3532/4885KMT2A 2603/4885
US-20170121344-A1 THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS TTPA, TPMT, SLC19A2 ALDH1A1 1400/4885MEN1 3532/4885KMT2A 2603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.